dc.date.accessioned2022-08-15T20:11:11Z
dc.date.available2022-08-15T20:11:11Z
dc.date.created2022-08-15T20:11:11Z
dc.date.issued2022
dc.identifierhttps://hdl.handle.net/20.500.12866/12069
dc.identifierhttps://doi.org/10.12688/wellcomeopenres.17795.1
dc.description.abstractThis report describes the MalariaGEN Pv4 dataset, a new release of curated genome variation data on 1,895 samples of Plasmodium vivax collected at 88 worldwide locations between 2001 and 2017. It includes 1,370 new samples contributed by MalariaGEN and VivaxGEN partner studies in addition to previously published samples from these and other sources. We provide genotype calls at over 4.5 million variable positions including over 3 million single nucleotide polymorphisms (SNPs), as well as short indels and tandem duplications. This enlarged dataset highlights major compartments of parasite population structure, with clear differentiation between Africa, Latin America, Oceania, Western Asia and different parts of Southeast Asia. Each sample has been classified for drug resistance to sulfadoxine, pyrimethamine and mefloquine based on known markers at the dhfr, dhps and mdr1 loci. The prevalence of all of these resistance markers was much higher in Southeast Asia and Oceania than elsewhere. This open resource of analysis-ready genome variation data from the MalariaGEN and VivaxGEN networks is driven by our collective goal to advance research into the complex biology of P. vivax and to accelerate genomic surveillance for malaria control and elimination.
dc.languageeng
dc.publisherF1000 Research
dc.relationWellcome Open Research
dc.relation2398-502X
dc.rightshttps://creativecommons.org/licenses/by-nc-nd/4.0/deed.es
dc.rightsinfo:eu-repo/semantics/restrictedAccess
dc.subjectMalaria
dc.subjectPlasmodium vivax
dc.subjectGenomics
dc.subjectData resource
dc.subjectGenomic epidemiology
dc.titleAn open dataset of Plasmodium vivax genome variation in 1,895 worldwide samples
dc.typeinfo:eu-repo/semantics/article


Este ítem pertenece a la siguiente institución